ANLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Adlai Nortye Group Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 10, 2026
$10.38−0.65 (-5.89%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Adlai Nortye Group Ltd. revenue by segment
By business segment
By product or service
| Revenue | FY2023 | FY2021 | % of revenue |
|---|---|---|---|
| Sales of an exclusive option [Member] | $5.00M | – | 100.0% |
| Sales of intellectual property [Member] | – | $45.73M | – |
By region
From the segment and revenue-disaggregation notes of Adlai Nortye's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.